EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study

Gülden Bilican, Seçkin Özgül, Nergiz Ekmen, Kenan Moral, Harun Küçük, Serkan Dumanlı, Azer Abiyev, Tarkan Karakan, Murat Kekilli

Journal of Gastrointestinal and Liver Diseases · 2023

DOI: 10.15403/jgld-4821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2023. Verfasst von Gülden Bilican und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Gazi University School of Medicine, 06560 Ankara, Turkey. guldenbilican@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Currently malignancies of the liver are the sixth most frequently diagnosed cancers worldwide. The admission of patients to hospitals decreased due to the restriction of the Coronavirus disease 2019 (COVİD-19) pandemic, especially patients suspected with cancer were delayed in their diagnosis and treatment. With this study, we aimed to investigate whether the Covid-19 pandemic caused a decrease in the number of hepatocellular cancers (HCC) or a delay in its diagnosis.

Methods

The study, which included newly diagnosed HCC patients, was conducted as a retrospective cross sectional study, in a single Turkey medical center. The patients were divided into pre-COVID-19 and post- COVID-19 two-year periods and compared in terms of tumor size, biochemical parameters, clinical and demographic features.

Results

A total of 63 HCC patients, 46 (73%) patients before the COVID-19 pandemic and 17 (27%) patients diagnosed during the COVID-19 pandemic were included. Maximum diameter of lesions and serum alpha- fetoprotein levels showed a statistically significant difference between the groups. Maximum tumor size in the pre-COVID-19 period was 4.58±3.77 mm, while in the COVID-19 period was 7.42±6.88 mm, the difference between two groups being statistically significant (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCOVID-19HumansPandemicsRetrospective StudiesCross-Sectional StudiesTurkeyNeoplasm Staging

Autor:innen und Institutionen

  • Department of Gastroenterology, Gazi University School of Medicine, 06560 Ankara, Turkey. guldenbilican@gmail.com.
  • Department of Gastroenterology, Gazi University School of Medicine, 06560 Ankara, Turkey.

Zitieren

APA

Bilican, G., Özgül, S., Ekmen, N., Moral, K., Küçük, H., Dumanlı, S., Abiyev, A., Karakan, T., & Kekilli, M. (2023). Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-4821

Vancouver

Bilican G, Özgül S, Ekmen N, Moral K, Küçük H, Dumanlı S, et al. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study. Journal of Gastrointestinal and Liver Diseases. 2023. doi:10.15403/jgld-4821

BibTeX
@article{Bilican2023,
  author = {Bilican, Gülden and Özgül, Seçkin and Ekmen, Nergiz and Moral, Kenan and Küçük, Harun and Dumanlı, Serkan and Abiyev, Azer and Karakan, Tarkan and Kekilli, Murat},
  title = {Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2023},
  doi = {10.15403/jgld-4821}
}
Kostenlos starten →